Clinical Trial Update: A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 study evaluating Samuraciclib in combination with Elacestrant in participants with metastatic or locally advanced HR+/HER2-negative breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Elacestrant (elacestrant)
• Samuraciclib (samuraciclib)

Snippet

Sponsor: Carrick Therapeutics Limited | Conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED